微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 11.93% | 13.94% | 121.75% | 16/159 | 1.21% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 5.38% | 3.66% | 74.68% | 29/159 | 0.26% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 3.08% | 1.32% | -69.63% | 30/159 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 10.14% | 214.91% | -3.15% | 30/159 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 10.47% | -19.89% | 101.73% | 23/159 | 4.23% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 5.19% | 218.4% | 70.72% | 37/159 | 2.66% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 3.04% | 149.18% | -5.59% | 33/159 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 3.22% | 118.61% | -75.36% | 78/159 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 13.07% | 732.48% | 701.84% | 9/159 | 2.34% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 1.63% | 16.43% | 33.61% | 90/159 | 1.46% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 1.22% | 2340% | 107.05% | 82/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -17.3% | -1126.95% | -1201.91% | 133/159 | 0.67% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 1.57% | -72.98% | 12.14% | 100/159 | 2.8% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 1.4% | -20.9% | 2700% | 96/159 | 2.16% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 0.05% | -95.76% | 103.55% | 113/159 | 1.57% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | -1.41% | 92.28% | -124.27% | 115/159 | 0.75% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 5.81% | -84.09% | 228.25% | 70/159 | 4.43% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 1.77% | 167.3% | 50% | 101/159 | 2.94% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 1.18% | -96.68% | 106.46% | 90/159 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | -18.26% | 79.07% | -150.01% | 129/159 | 3.58% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 36.51% | 426.84% | 1488.21% | 3/159 | 3.03% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | -2.63% | -156.08% | -107.4% | 115/159 | 4.19% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 35.56% | 1714.29% | 140.76% | 1/159 | 2.19% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | -87.25% | -436350% | -1359.02% | 133/159 | 2.53% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 6.93% | -4.41% | 47.76% | 51/159 | 7.48% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 4.69% | -3.3% | 139.29% | 50/159 | 4.96% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 1.96% | -15.52% | 9700% | 56/159 | 2.41% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 0.02% | -99.68% | -99.72% | 117/159 | 6.99% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 7.25% | 2.84% | 49.48% | 43/159 | 7.18% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 4.85% | -9.68% | 109.05% | 42/159 | 4.6% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 2.32% | -22.92% | -63.41% | 46/159 | 2.54% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 6.34% | -64.06% | -10.07% | 75/159 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 7.05% | -55.41% | 31.28% | 48/159 | 8.29% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 5.37% | -40.6% | 78.41% | 38/159 | 5.58% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 3.01% | -36.36% | -82.94% | 26/159 | 2.09% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 17.64% | -5.72% | 11.57% | 30/159 | 6.19% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 15.81% | 2.33% | 74.89% | 11/159 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 9.04% | -8.13% | 91.12% | 19/159 | 3.48% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 4.73% | 16.5% | -74.72% | 13/159 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 18.71% | 25.91% | 21.1% | 23/159 | 11.27% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 15.45% | 30.93% | 57.01% | 10/159 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 9.84% | 28.46% | 142.36% | 13/159 | 4.87% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 4.06% | 46.04% | -72.68% | 17/159 | 2.41% | 华东医药 | 26.63% | 行业排名> |